Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 19 of 19 for “"T cell engineering"”.
-
Ionizable lipid nanoparticles for mRNA CAR T cell engineering
Chimeric antigen receptor (CAR) T cell immunotherapy is FDA approved for the treatment of many blood cancers including acute lymphoblastic leukemia (ALL), large B cell lymphoma, and multiple myeloma with demonstrated success in inducing durable remissions. However, the therapy is also associated …
-
(Macro)molecular strategies for lipid nanoparticles and T cell engineering
Over the past years, the immense potential of mRNA-lipid nanoparticle (LNP) formulations has become evident, particularly with the emergence of Covid-19 vaccines. The fast, relatively simple, and scalable manufacturing process of mRNA LNP formulations played a crucial role in combatting the global …
-
T cell receptor redirected T cells in tumour immunotherapy
<p>Adoptive T cell transfer has revolutionized the field of cancer immunotherapy due to the specificity and effectiveness, particularly for haematological malignancies. However, challenges still remain in achieving a satisfactory therapeutic response in solid tumours. Additionally, the potential …
-
Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors
… targets in low mutational solid tumors, and the engineering of T cells to recognize tumor-specific self-antigens. Using neuroblastoma, an aggressive, low mutational, cold tumor, we developed a process combining proteomics of MHC-presented antigens with computational methods and …
-
Engineering of chimeric antigen receptor T cells with enhanced therapeutic index in cancer immunotherapy using non-viral gene transfer and genome editing
The advances in genetic engineering have enabled us to confer T cells new desired functions or delete their specific undesired endogenous properties for improving their antitumor function. Due to their efficient gene delivery, viral vectors have been successfully used in T-cell engineering to …
-
Engineering Metabolically Weaponized T Cell Therapies for Solid Tumor Translation
Chimeric Antigen Receptors (CAR) T cell therapies are revolutionizing treatment of cancer in hematological malignancies, eclipsing 50-90% response rates for refractory, or previously non-responding cancers. If we could recapitulate even a fraction of this efficacy for solid tumor indications, it …
-
Development of BCMA-specific engineered T cells targeting multiple myeloma
Multiple myeloma is a plasma cell cancer that progressively evolves to an aggressive, multi-drug resistant disease, which presents an unmet clinical need. In clinical trials, myeloma shows susceptibility to novel immunotherapeutic agents, particularly those targeting B-cell maturation antigen …
-
Postbiotika-vermittelte metabolische Modulation von CAR-T-Zellen zur Optimierung der Krebsimmuntherapie
… using chimeric antigen receptor (CAR) T cells has revolutionized the treatment of hematological malignancies. Despite huge clinical successes for cancer entities such as multiple myeloma and lymphoma, treatment of solid tumors remains challenging. Factors in the tumor microenvironment …
-
Multifunctional Nanoparticle Platforms for Nucleic Acid Delivery, Cancer Therapy, and Immune Cell Engineering
… conventional treatments. Gene therapy and immune-cell engineering have emerged as promising strategies for addressing these challenges because they enable precise modulation of cellular behavior and therapeutic protein expression. However, the successful clinical application of nucleic-acid …
-
Mapping the Molecular Ontogeny of Non-Hodgkin Lymphomas
… recipient after allogeneic hematopoietic stem cell (HSC) transplantation suggest that some lymphoid neoplasms originate from the HSC compartment. Notably, mutated HSCs can undergo clonal expansion, a condition known as clonal hematopoiesis (CH), which has been linked to the development of …
-
Developing an ‘Off-the-Shelf’ Engineered γδ T Cell Therapy for Multiple Myeloma
Multiple myeloma is a plasma cell malignancy with limited treatment options and a poor prognosis in those with relapsed/refractory disease. In recent years, adoptive transfer of genetically engineered T cells, such as chimeric antigen receptor (CAR)-T cell therapy has realized remarkable clinical …
-
Ανάπτυξη και αξιολόγηση πειραματικού συστήματος κυτταρικής ανοσοθεραπείας του καρκίνου των ωοθηκών
T cell-based adoptive immunotherapy is a promising approach for the therapy of patients with advanced epithelial ovarian cancer (EOC). However, adoptive T cell therapy currently requires the isolation and characterization of rare antigen-specific T cells from each patient thus limiting its broad …
-
synZiFTR2.0: the development of improved synthetic human transcription activation factors
… therapeutically significant genes in primary T cells. However, their clinical relevance could be enhanced by amplifying synthetic gene circuit activation and expanding the synZiFTR toolkit with standardized compo-nents for the construction of more complex circuits. This study describes the …
-
ENGINEERING MRNA LIPID NANOPARTICLES TO COMBAT INFLAMMATORY AND AUTOIMMUNE DISEASE
… contexts — leaving a substantial gap in both cell-based and in situ therapeutic strategies. Addressing this gap, the primary objective of this thesis was to establish rational design principles for engineering mRNA LNP formulations capable of safe and effective deployment in inflammatory and …
-
Reprogramming Exhausted Cytotoxic T Cells Through Transcription Factor Overexpression
<p>T cells are part of the immune system’s adaptive defence; they specifically target and kill both virally infected and cancerous cells through antigen recognition. During an acute infection, effector T cells (TEFF) mount a robust response to ultimately clear all virally infected cells. Since T …
-
Engineering human autoimmune T cell receptors towards the development of a cellular therapy for multiple sclerosis
… autoimmune disorder caused by autoreactive T cells that recognize and initiate immune attack of the myelin sheath that protects neurons of the central nervous system. Over time, this results in scarring or destruction of the affected tissue, and cerebellar atrophy. Existing therapies are …
-
In vivo and in vitro generation of tumor antigen-specific T cells using human CD34+ hematopoietic stem cells or engineered mature T cells
… to standard-of-care treatments. Adoptive cell trans-fer (ACT) lies in the heart of cellular immunotherapies and involves the isolation, expansion, and rejuvenation of a patient’s T cells before reinfusion. Still, reintroduced T cells suffer from poor in vivo persistence and activity, …